sales@marketbusinessinsights.com | +1 (518)-300-1070
Market Business Insights Glioblastoma Multiforme Treatment Market
Request Sample Buy Now

Table Of Contents 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Bevacizumab (Avastin)
        1.2.3 Carmustine (BiCNU)
        1.2.4 Temozolomide (Temodar and Temodal and Temcad)
    1.3 Market by Application
        1.3.1 Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Glioblastoma Multiforme Treatment Market Perspective (2017-2028)
    2.2 Glioblastoma Multiforme Treatment Growth Trends by Region
        2.2.1 Glioblastoma Multiforme Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Glioblastoma Multiforme Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Glioblastoma Multiforme Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Glioblastoma Multiforme Treatment Market Dynamics
        2.3.1 Glioblastoma Multiforme Treatment Industry Trends
        2.3.2 Glioblastoma Multiforme Treatment Market Drivers
        2.3.3 Glioblastoma Multiforme Treatment Market Challenges
        2.3.4 Glioblastoma Multiforme Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Glioblastoma Multiforme Treatment Players by Revenue
        3.1.1 Global Top Glioblastoma Multiforme Treatment Players by Revenue (2017-2022)
        3.1.2 Global Glioblastoma Multiforme Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Glioblastoma Multiforme Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Glioblastoma Multiforme Treatment Revenue
    3.4 Global Glioblastoma Multiforme Treatment Market Concentration Ratio
        3.4.1 Global Glioblastoma Multiforme Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Glioblastoma Multiforme Treatment Revenue in 2021
    3.5 Glioblastoma Multiforme Treatment Key Players Head office and Area Served
    3.6 Key Players Glioblastoma Multiforme Treatment Product Solution and Service
    3.7 Date of Enter into Glioblastoma Multiforme Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Glioblastoma Multiforme Treatment Breakdown Data by Type
    4.1 Global Glioblastoma Multiforme Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Glioblastoma Multiforme Treatment Forecasted Market Size by Type (2023-2028)
5 Glioblastoma Multiforme Treatment Breakdown Data by Application
    5.1 Global Glioblastoma Multiforme Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Glioblastoma Multiforme Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Glioblastoma Multiforme Treatment Market Size (2017-2028)
    6.2 North America Glioblastoma Multiforme Treatment Market Size by Type
        6.2.1 North America Glioblastoma Multiforme Treatment Market Size by Type (2017-2022)
        6.2.2 North America Glioblastoma Multiforme Treatment Market Size by Type (2023-2028)
        6.2.3 North America Glioblastoma Multiforme Treatment Market Share by Type (2017-2028)
    6.3 North America Glioblastoma Multiforme Treatment Market Size by Application
        6.3.1 North America Glioblastoma Multiforme Treatment Market Size by Application (2017-2022)
        6.3.2 North America Glioblastoma Multiforme Treatment Market Size by Application (2023-2028)
        6.3.3 North America Glioblastoma Multiforme Treatment Market Share by Application (2017-2028)
    6.4 North America Glioblastoma Multiforme Treatment Market Size by Country
        6.4.1 North America Glioblastoma Multiforme Treatment Market Size by Country (2017-2022)
        6.4.2 North America Glioblastoma Multiforme Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Glioblastoma Multiforme Treatment Market Size (2017-2028)
    7.2 Europe Glioblastoma Multiforme Treatment Market Size by Type
        7.2.1 Europe Glioblastoma Multiforme Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Glioblastoma Multiforme Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Glioblastoma Multiforme Treatment Market Share by Type (2017-2028)
    7.3 Europe Glioblastoma Multiforme Treatment Market Size by Application
        7.3.1 Europe Glioblastoma Multiforme Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Glioblastoma Multiforme Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Glioblastoma Multiforme Treatment Market Share by Application (2017-2028)
    7.4 Europe Glioblastoma Multiforme Treatment Market Size by Country
        7.4.1 Europe Glioblastoma Multiforme Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Glioblastoma Multiforme Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Glioblastoma Multiforme Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Type
        8.2.1 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Glioblastoma Multiforme Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Application
        8.3.1 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Glioblastoma Multiforme Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Region
        8.4.1 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Glioblastoma Multiforme Treatment Market Size (2017-2028)
    9.2 Latin America Glioblastoma Multiforme Treatment Market Size by Type
        9.2.1 Latin America Glioblastoma Multiforme Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Glioblastoma Multiforme Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Glioblastoma Multiforme Treatment Market Share by Type (2017-2028)
    9.3 Latin America Glioblastoma Multiforme Treatment Market Size by Application
        9.3.1 Latin America Glioblastoma Multiforme Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Glioblastoma Multiforme Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Glioblastoma Multiforme Treatment Market Share by Application (2017-2028)
    9.4 Latin America Glioblastoma Multiforme Treatment Market Size by Country
        9.4.1 Latin America Glioblastoma Multiforme Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Glioblastoma Multiforme Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Glioblastoma Multiforme Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Type
        10.2.1 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Glioblastoma Multiforme Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Application
        10.3.1 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Glioblastoma Multiforme Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Country
        10.4.1 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie, Inc
        11.1.1 AbbVie, Inc Company Details
        11.1.2 AbbVie, Inc Business Overview
        11.1.3 AbbVie, Inc Glioblastoma Multiforme Treatment Introduction
        11.1.4 AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.1.5 AbbVie, Inc Recent Developments
    11.2 Activartis GmbH
        11.2.1 Activartis GmbH Company Details
        11.2.2 Activartis GmbH Business Overview
        11.2.3 Activartis GmbH Glioblastoma Multiforme Treatment Introduction
        11.2.4 Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.2.5 Activartis GmbH Recent Developments
    11.3 Agenus Inc
        11.3.1 Agenus Inc Company Details
        11.3.2 Agenus Inc Business Overview
        11.3.3 Agenus Inc Glioblastoma Multiforme Treatment Introduction
        11.3.4 Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.3.5 Agenus Inc Recent Developments
    11.4 Arog Pharmaceuticals, Inc
        11.4.1 Arog Pharmaceuticals, Inc Company Details
        11.4.2 Arog Pharmaceuticals, Inc Business Overview
        11.4.3 Arog Pharmaceuticals, Inc Glioblastoma Multiforme Treatment Introduction
        11.4.4 Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.4.5 Arog Pharmaceuticals, Inc Recent Developments
    11.5 Bristol-Myers Squibb Company
        11.5.1 Bristol-Myers Squibb Company Company Details
        11.5.2 Bristol-Myers Squibb Company Business Overview
        11.5.3 Bristol-Myers Squibb Company Glioblastoma Multiforme Treatment Introduction
        11.5.4 Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.5.5 Bristol-Myers Squibb Company Recent Developments
    11.6 Cavion LLC
        11.6.1 Cavion LLC Company Details
        11.6.2 Cavion LLC Business Overview
        11.6.3 Cavion LLC Glioblastoma Multiforme Treatment Introduction
        11.6.4 Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.6.5 Cavion LLC Recent Developments
    11.7 Celldex Therapeutics Inc
        11.7.1 Celldex Therapeutics Inc Company Details
        11.7.2 Celldex Therapeutics Inc Business Overview
        11.7.3 Celldex Therapeutics Inc Glioblastoma Multiforme Treatment Introduction
        11.7.4 Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.7.5 Celldex Therapeutics Inc Recent Developments
    11.8 Cortice Biosciences
        11.8.1 Cortice Biosciences Company Details
        11.8.2 Cortice Biosciences Business Overview
        11.8.3 Cortice Biosciences Glioblastoma Multiforme Treatment Introduction
        11.8.4 Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.8.5 Cortice Biosciences Recent Developments
    11.9 Exelixis Inc
        11.9.1 Exelixis Inc Company Details
        11.9.2 Exelixis Inc Business Overview
        11.9.3 Exelixis Inc Glioblastoma Multiforme Treatment Introduction
        11.9.4 Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.9.5 Exelixis Inc Recent Developments
    11.10 F. Hoffmann-La Roche Ltd.
        11.10.1 F. Hoffmann-La Roche Ltd. Company Details
        11.10.2 F. Hoffmann-La Roche Ltd. Business Overview
        11.10.3 F. Hoffmann-La Roche Ltd. Glioblastoma Multiforme Treatment Introduction
        11.10.4 F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2017-2022)
        11.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Bevacizumab (Avastin)
    Table 3. Key Players of Carmustine (BiCNU)
    Table 4. Key Players of Temozolomide (Temodar and Temodal and Temcad)
    Table 5. Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Glioblastoma Multiforme Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Glioblastoma Multiforme Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Glioblastoma Multiforme Treatment Market Share by Region (2017-2022)
    Table 9. Global Glioblastoma Multiforme Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Glioblastoma Multiforme Treatment Market Share by Region (2023-2028)
    Table 11. Glioblastoma Multiforme Treatment Market Trends
    Table 12. Glioblastoma Multiforme Treatment Market Drivers
    Table 13. Glioblastoma Multiforme Treatment Market Challenges
    Table 14. Glioblastoma Multiforme Treatment Market Restraints
    Table 15. Global Glioblastoma Multiforme Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Glioblastoma Multiforme Treatment Revenue Share by Players (2017-2022)
    Table 17. Global Top Glioblastoma Multiforme Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glioblastoma Multiforme Treatment as of 2021)
    Table 18. Ranking of Global Top Glioblastoma Multiforme Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Glioblastoma Multiforme Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Glioblastoma Multiforme Treatment Product Solution and Service
    Table 22. Date of Enter into Glioblastoma Multiforme Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Glioblastoma Multiforme Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Glioblastoma Multiforme Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Glioblastoma Multiforme Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Glioblastoma Multiforme Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Glioblastoma Multiforme Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Glioblastoma Multiforme Treatment Revenue Share by Application (2017-2022)
    Table 30. Global Glioblastoma Multiforme Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Glioblastoma Multiforme Treatment Revenue Share by Application (2023-2028)
    Table 32. North America Glioblastoma Multiforme Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Glioblastoma Multiforme Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Glioblastoma Multiforme Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Glioblastoma Multiforme Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Glioblastoma Multiforme Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Glioblastoma Multiforme Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Glioblastoma Multiforme Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Glioblastoma Multiforme Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Glioblastoma Multiforme Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Glioblastoma Multiforme Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Glioblastoma Multiforme Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Glioblastoma Multiforme Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Glioblastoma Multiforme Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Glioblastoma Multiforme Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Glioblastoma Multiforme Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Glioblastoma Multiforme Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Glioblastoma Multiforme Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Glioblastoma Multiforme Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Glioblastoma Multiforme Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Glioblastoma Multiforme Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Glioblastoma Multiforme Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Glioblastoma Multiforme Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Glioblastoma Multiforme Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Glioblastoma Multiforme Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Glioblastoma Multiforme Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Glioblastoma Multiforme Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Glioblastoma Multiforme Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Glioblastoma Multiforme Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Glioblastoma Multiforme Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Glioblastoma Multiforme Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 62. AbbVie, Inc Company Details
    Table 63. AbbVie, Inc Business Overview
    Table 64. AbbVie, Inc Glioblastoma Multiforme Treatment Product
    Table 65. AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 66. AbbVie, Inc Recent Developments
    Table 67. Activartis GmbH Company Details
    Table 68. Activartis GmbH Business Overview
    Table 69. Activartis GmbH Glioblastoma Multiforme Treatment Product
    Table 70. Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 71. Activartis GmbH Recent Developments
    Table 72. Agenus Inc Company Details
    Table 73. Agenus Inc Business Overview
    Table 74. Agenus Inc Glioblastoma Multiforme Treatment Product
    Table 75. Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 76. Agenus Inc Recent Developments
    Table 77. Arog Pharmaceuticals, Inc Company Details
    Table 78. Arog Pharmaceuticals, Inc Business Overview
    Table 79. Arog Pharmaceuticals, Inc Glioblastoma Multiforme Treatment Product
    Table 80. Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 81. Arog Pharmaceuticals, Inc Recent Developments
    Table 82. Bristol-Myers Squibb Company Company Details
    Table 83. Bristol-Myers Squibb Company Business Overview
    Table 84. Bristol-Myers Squibb Company Glioblastoma Multiforme Treatment Product
    Table 85. Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 86. Bristol-Myers Squibb Company Recent Developments
    Table 87. Cavion LLC Company Details
    Table 88. Cavion LLC Business Overview
    Table 89. Cavion LLC Glioblastoma Multiforme Treatment Product
    Table 90. Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 91. Cavion LLC Recent Developments
    Table 92. Celldex Therapeutics Inc Company Details
    Table 93. Celldex Therapeutics Inc Business Overview
    Table 94. Celldex Therapeutics Inc Glioblastoma Multiforme Treatment Product
    Table 95. Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 96. Celldex Therapeutics Inc Recent Developments
    Table 97. Cortice Biosciences Company Details
    Table 98. Cortice Biosciences Business Overview
    Table 99. Cortice Biosciences Glioblastoma Multiforme Treatment Product
    Table 100. Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 101. Cortice Biosciences Recent Developments
    Table 102. Exelixis Inc Company Details
    Table 103. Exelixis Inc Business Overview
    Table 104. Exelixis Inc Glioblastoma Multiforme Treatment Product
    Table 105. Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 106. Exelixis Inc Recent Developments
    Table 107. F. Hoffmann-La Roche Ltd. Company Details
    Table 108. F. Hoffmann-La Roche Ltd. Business Overview
    Table 109. F. Hoffmann-La Roche Ltd. Glioblastoma Multiforme Treatment Product
    Table 110. F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2017-2022) & (US$ Million)
    Table 111. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Glioblastoma Multiforme Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Bevacizumab (Avastin) Features
    Figure 3. Carmustine (BiCNU) Features
    Figure 4. Temozolomide (Temodar and Temodal and Temcad) Features
    Figure 5. Global Glioblastoma Multiforme Treatment Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Others Case Studies
    Figure 9. Glioblastoma Multiforme Treatment Report Years Considered
    Figure 10. Global Glioblastoma Multiforme Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Glioblastoma Multiforme Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Glioblastoma Multiforme Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Glioblastoma Multiforme Treatment Market Share by Players in 2021
    Figure 14. Global Top Glioblastoma Multiforme Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glioblastoma Multiforme Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Glioblastoma Multiforme Treatment Revenue in 2021
    Figure 16. North America Glioblastoma Multiforme Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Glioblastoma Multiforme Treatment Market Size Market Share by Type (2017-2028)
    Figure 18. North America Glioblastoma Multiforme Treatment Market Size Market Share by Application (2017-2028)
    Figure 19. North America Glioblastoma Multiforme Treatment Market Size Share by Country (2017-2028)
    Figure 20. United States Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Glioblastoma Multiforme Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Glioblastoma Multiforme Treatment Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Glioblastoma Multiforme Treatment Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Glioblastoma Multiforme Treatment Market Size Share by Country (2017-2028)
    Figure 26. Germany Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Glioblastoma Multiforme Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Glioblastoma Multiforme Treatment Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Glioblastoma Multiforme Treatment Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Glioblastoma Multiforme Treatment Market Size Share by Region (2017-2028)
    Figure 36. China Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Glioblastoma Multiforme Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Glioblastoma Multiforme Treatment Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Glioblastoma Multiforme Treatment Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Glioblastoma Multiforme Treatment Market Size Share by Country (2017-2028)
    Figure 46. Mexico Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Glioblastoma Multiforme Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Glioblastoma Multiforme Treatment Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Glioblastoma Multiforme Treatment Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Glioblastoma Multiforme Treatment Market Size Share by Country (2017-2028)
    Figure 52. Turkey Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Glioblastoma Multiforme Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. AbbVie, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 56. Activartis GmbH Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 57. Agenus Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 58. Arog Pharmaceuticals, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 59. Bristol-Myers Squibb Company Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 60. Cavion LLC Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 61. Celldex Therapeutics Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 62. Cortice Biosciences Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 63. Exelixis Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 64. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
  1. Global Market, By Product Types, 2018-2028 (USD Million)
  2. Global Market, By Applications, 2018-2028 (USD Million)
  3. Global Secure Messaging, Glioblastoma Multiforme Treatment Market, By Region, 2018-2028 (USD Million)
  4. Global Web Portal, Glioblastoma Multiforme Treatment Market, By Region, 2018-2028 (USD Million)
  5. Global Private, Glioblastoma Multiforme Treatment Market, By Region, 2018-2028 (USD Million)
  6. Global Public,Glioblastoma Multiforme Treatment Market, By Region, 2018-2028 (USD Million)
  7. North America Market, By Product Types, 2018-2028 (USD Million)
  8. North America Market, By Applications, 2018-2028 (USD Million)
  9. U.S. Market, By Product Types, 2018-2028 (USD Million)
  10. U.S. Market, By Applications, 2018-2028 (USD Million)
  11. Canada Market, By Product Types, 2018-2028 (USD Million)
  12. Canada Market, By Applications, 2018-2028 (USD Million)
  13. Mexico Market, By Product Types, 2018-2028 (USD Million)
  14. Mexico Market, By Applications, 2018-2028 (USD Million)
  15. Europe Market, By Product Types, 2018-2028 (USD Million)
  16. Europe Market, By Applications, 2018-2028 (USD Million)
  17. U.K. Market, By Product Types, 2018-2028 (USD Million)
  18. U.K. Market, By Applications, 2018-2028 (USD Million)
  19. Germany Market, By Product Types, 2018-2028 (USD Million)
  20. Germany Market, By Applications, 2018-2028 (USD Million)
  21. Italy Market, By Product Types, 2018-2028 (USD Million)
  22. Italy Market, By Applications, 2018-2028 (USD Million)
  23. France Market, By Product Types, 2018-2028 (USD Million)
  24. France Market, By Applications, 2018-2028 (USD Million)
  25. Russia Market, By Product Types, 2018-2028 (USD Million)
  26. Russia Market, By Applications, 2018-2028 (USD Million)
  27. Asia-Pacific Market, By Product Types, 2018-2028 (USD Million)
  28. Asia-Pacific Market, By Applications, 2018-2028 (USD Million)
  29. India Market, By Product Types, 2018-2028 (USD Million)
  30. India Market, By Applications, 2018-2028 (USD Million)
  31. Japan Market, By Product Types, 2018-2028 (USD Million)
  32. Japan Market, By Applications, 2018-2028 (USD Million)
  33. China Market, By Product Types, 2018-2028 (USD Million)
  34. China Market, By Applications, 2018-2028 (USD Million)
  35. South Korea Market, By Product Types, 2018-2028 (USD Million)
  36. South Korea Market, By Applications, 2018-2028 (USD Million)
  37. Australia Market, By Product Types, 2018-2028 (USD Million)
  38. Australia Market, By Applications, 2018-2028 (USD Million)
  39. Latin America Market, By Product Types, 2018-2028 (USD Million)
  40. Latin America Market, By Applications, 2018-2028 (USD Million)
  41. Brazil Market, By Product Types, 2018-2028 (USD Million)
  42. Brazil Market, By Applications, 2018-2028 (USD Million)
  43. Middle East & Africa Market, By Product Types, 2018-2028 (USD Million)
  44. Middle East & Africa Market, By Applications, 2018-2028 (USD Million)
  45. Saudi Arabia Market, By Product Types, 2018-2028 (USD Million)
  46. Saudi Arabia Market, By Applications, 2018-2028 (USD Million)
  47. UAE Market, By Product Types, 2018-2028 (USD Million)
  48. UAE Market, By Applications, 2018-2028 (USD Million)
  49. South Africa Market, By Product Types, 2018-2028 (USD Million)
  50. South Africa Market, By Applications, 2018-2028 (USD Million)
  1. Global Glioblastoma Multiforme Treatment Market Segmentation
  2. Global Glioblastoma Multiforme Treatment Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-Down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Global Market Attractiveness Analysis By Product Types
  9. Global Market Attractiveness Analysis By Applications
  10. Global Glioblastoma Multiforme Treatment Market Attractiveness Analysis ByRegion
  11. Global Glioblastoma Multiforme Treatment Market: Dynamics
  12. Global Market Share By Product Types (2021 & 2028)
  13. Global Market Share By Applications (2021 & 2028)
  14. Global Glioblastoma Multiforme Treatment Market Share By Region (2021 & 2028)
  15. Global Glioblastoma Multiforme Treatment Market Share By Company (2020)
We Accept
Select License
Includes
  • Purchase Report Sections
  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Latest Reports